Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Tyrer

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Plos Genetics|October 27, 2011
HIF-VEGF pathways are critical for chronic otitis media in Junbo and Jeff mouse mutantsMichael T Cheeseman, Hayley E Tyrer, Debbie Williams, et al.
Plos Genetics|August 15, 2017
A mutation in Nischarin causes otitis media via LIMK1 and NF-κB pathwaysMichael Crompton, Tom Purnell, Hayley E Tyrer, et al.
Scientific Reports|March 22, 2016
Minocycline as a re-purposed anti-Wolbachia macrofilaricide: superiority compared with doxycycline regimens in a murine infection model of human lymphatic filariasisRaman Sharma, Ghaith Al Jayoussi, Hayley E Tyrer, et al.
Scientific Reports|January 9, 2018
Corrigendum: Minocycline as a re-purposed anti-Wolbachia macrofilaricide: superiority compared with doxycycline regimens in a murine infection model of human lymphatic filariasisRaman Sharma, Ghaith Aljayyoussi, Hayley E Tyrer, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 29, 2017
Albendazole and antibiotics synergize to deliver short-course anti-<i>Wolbachia</i> curative treatments in preclinical models of filariasisJoseph D Turner, Raman Sharma, Ghaith Al Jayoussi, et al.
Scientific Reports|March 18, 2017
Short-Course, High-Dose Rifampicin Achieves Wolbachia Depletion Predictive of Curative Outcomes in Preclinical Models of Lymphatic Filariasis and OnchocerciasisGhaith Aljayyoussi, Hayley E Tyrer, Louise Ford, et al.
Scientific Reports|January 20, 2018
Author Correction: Short-Course, High-Dose Rifampicin Achieves Wolbachia Depletion Predictive of Curative Outcomes in Preclinical Models of Lymphatic Filariasis and OnchocerciasisGhaith Aljayyoussi, Hayley E Tyrer, Louise Ford, et al.
Science Translational Medicine|March 15, 2019
Preclinical development of an oral anti-<i>Wolbachia</i> macrolide drug for the treatment of lymphatic filariasis and onchocerciasisMark J Taylor, Thomas W von Geldern, Louise Ford, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Plos Genetics|October 27, 2011
HIF-VEGF pathways are critical for chronic otitis media in Junbo and Jeff mouse mutantsMichael T Cheeseman, Hayley E Tyrer, Debbie Williams, et al.
Plos Genetics|August 15, 2017
A mutation in Nischarin causes otitis media via LIMK1 and NF-κB pathwaysMichael Crompton, Tom Purnell, Hayley E Tyrer, et al.
Scientific Reports|March 22, 2016
Minocycline as a re-purposed anti-Wolbachia macrofilaricide: superiority compared with doxycycline regimens in a murine infection model of human lymphatic filariasisRaman Sharma, Ghaith Al Jayoussi, Hayley E Tyrer, et al.
Scientific Reports|January 9, 2018
Corrigendum: Minocycline as a re-purposed anti-Wolbachia macrofilaricide: superiority compared with doxycycline regimens in a murine infection model of human lymphatic filariasisRaman Sharma, Ghaith Aljayyoussi, Hayley E Tyrer, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 29, 2017
Albendazole and antibiotics synergize to deliver short-course anti-<i>Wolbachia</i> curative treatments in preclinical models of filariasisJoseph D Turner, Raman Sharma, Ghaith Al Jayoussi, et al.
Scientific Reports|March 18, 2017
Short-Course, High-Dose Rifampicin Achieves Wolbachia Depletion Predictive of Curative Outcomes in Preclinical Models of Lymphatic Filariasis and OnchocerciasisGhaith Aljayyoussi, Hayley E Tyrer, Louise Ford, et al.
Scientific Reports|January 20, 2018
Author Correction: Short-Course, High-Dose Rifampicin Achieves Wolbachia Depletion Predictive of Curative Outcomes in Preclinical Models of Lymphatic Filariasis and OnchocerciasisGhaith Aljayyoussi, Hayley E Tyrer, Louise Ford, et al.
Science Translational Medicine|March 15, 2019
Preclinical development of an oral anti-<i>Wolbachia</i> macrolide drug for the treatment of lymphatic filariasis and onchocerciasisMark J Taylor, Thomas W von Geldern, Louise Ford, et al.
Pageof 2